Please find enclosed herewith the AGM Proceedings held today i.e. September 29, 2026.

& e Darnax Lab Ltd. TEL 1 022 - 6825 2525 E-Mail info@naxparlab.com Visi: ifssalk & i, ekraRIE, Bam (Formerly Known as Krishna Deep Trade & Investment Ld.) CIN No. : L36812MH1882PLC027325 114, BLDG, NO. 8, JOGANI IND. COMPLEX, SION-CHUNABHATTI, MUMBAL - 400 022, INDIA Date: September 29,2026 Listing Department BSE Ltd 1st Floor, New Trade Wing, Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai - 400 001 Scrip Code: 506128 Subject: Proceedings of the 44t Annual General Meeting (AGM) of the Company held today i.e,, Tuesday, September 29, 2026, at 12:30 P.M. Dear Sir/Madam, Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations) read with Para A of Part A of Schedule I1I to the Listing Regulations, we hereby enclose Proceedings of the 44t Annual General Meeting of the Members of the Company held on today i.e. Tuesday, September 29, 2026, at 12:30 PM (IST) through Video Conferencing / Other Audio-Visual Means (VC/0AVM) and concluded at 01:07 PM (IST), (including the time allowed for e-voting at AGM) for your record. The aforesaid proceedings of 44t AGM are also being uploaded on the Company’s website at www.naxparlab.com. The Voting Results of 44t AGM, as required under Regulation 44(3) of the Listing Regulations, will be submitted separately in due course. Kindly take the same on your record and oblige. Please Acknowledge the receipt of the same. Thanking You, Yours Faithfully, For Parnax Lab Limited PREET Digitally signed by PREET VUAY VIJAY KUKREJA KUKREJA mistn somm Preet Kukreja Company Secretary & Compliance Officer ACSNo.:56761 Woarks : Plot No. 120, Masat Ind. Estate, Dadra & Nagar Haveli, Silvassa-396230 (India) Plot No. 121 & 74, Masat Ind. Estate, Dadra & Nagar Haveli, Silvassa-336230 (India) TL EL. : 022 - 6825 2525 Darnax Lab Ltd. 5;::25 st x:s\?:::g:;‘:g g:z (Formerly Known as Krishna Deep Trade & Investment Ltd.) CIN No. : L36912MH1982PLC027325 114, BLDG, NO. 8, JOGANI IND. COMPLEX, SION-CHUNABHATTI, MUMBAI - 400 022, INDIA SUMMARY OF THE PROCEEDINGS OF 44t ANNUAL GENERAL MEETING (AGM) OF PARNAX LAB LIMITED (THE COMPANY) HELD ON TUESDAY, SEPTEMBER 29, 2026, AT 12:30 P.M. THROUGH VIDEO CONFERENCING/ OTHER AUDIO-VISUAL MEANS. Date, Time & Venue of the Meeting: The 44% Annual General Meeting (AGM) of Parnax Lab Limited (the Company) was held on Tuesday, September 29, 2026, at 12:30 P.M through Video Conferencing/ Other Audio- Visual | Means. Proceedings in brief: Mr. Mihir Shah - Chairman & Managing Director of the Company took the Chair. The meeting was virtually attended by 41 Members. Six Directors were present at the meeting including Mr. Yogesh Varia - the Chairman of the Audit Committee, Stakeholders Relationship Committee, and Nomination and Remuneration Committee of the Company. The Statutory Auditor & Secretarial Auditor also attended the meeting. Ms. Preet Kukreja — Company Secretary & Compliance Officer of the Company, welcomed the Members to the 44% AGM and briefed the meeting on a few points regarding participation in the meeting electronically. Thereafter, she introduced all the other directors oft he Company. All the directors including the Chairperson of the Audit Committee, Stakeholders’ Relationship Committee and Nomination and Remuneration Committee attended the meeting through VC. Secretarial Auditor and Statutory Auditors of the Company also attended the meeting through VC. As Requisite Members being virtually attended the meeting, the Chairman declared the meeting as validly convened as per terms of Section 103 of Companies Act, 2013 and as per the Articles of Association of the Company After a formal introduction of the Board Members, the Chairman stated about 44 years of incredible journey, with synergy between our management, investors, customers, suppliers, and employees, paved the way to become a leading contract manufacturer for pharmaceutical formulations in various dosage forms like Liquid, Ointment, Powder, Cosmetic, Herbal etc. with a significant global footprint. The Chairman then delivered his speech regarding Macroeconomic Outlook, Company’s Performance, Financial Performance, New Business Orders, New Product development, PICS Approval, Customer Expansion, Future expansion, Strong Revenue Growth, EBITDA Growth. The Chairman then took up the formal proceedings of the meeting, with the concurrence of the members the Notice of 44t Annual General Meeting together with the Financial Statements and Director’s Report were taken as read. The Company Secretary informed that there were no qualifications, adverse remarks, or opinions in the Statutory Auditor’s report. Further, observations of Secretarial Auditors are sufficientl replied to in the Board’s Report by the Management. “\ax & Works : Plot No. 120, Masat Ind. Estate, Dadra & Nagar Haveli, Silvassa-396230 (india) M Plot No. 121 & 74, Masat Ind. Estate, Dadra & Nagar Haveli, Silvassa-396230 (India Darnax Lab Ltd. \E/.'Mta" . : '"fD@"axgz::as'cs:: (Formerly Known as Krishna Deep Trade & Investment Lid.) Isit us at : www. nax aD. C CIN No. : L36812MH1882PLC027325 114, BLDG, NO. 8, JOGANI IND. COMPLEX, SION-CHUNABHATTI, MUMBAI - 400 022, INDIA With the permission of the Members present, the Notice of the Annual General Meeting, Financial Statements along with Boards' Report and Auditors’ Report thereon for F.Y. 2025-26 forming part of Annual Report was taken as read. The following items as stated in the Notice of 44t AGM were then taken into consideration: Item Details of Resolution Resolution Type ORDINARY BUSINESS: 1, To receive, consider and adopt the standalone and Ordinary Resolution consolidated audited annual accounts for the year ended March 31, 2026, along with notes thereon as on that date and the Reports of Board of Directors and Auditors thereon 2. To appoint a Director in place of Mr. Mihir P. Shah Ordinary Resolution (DIN: 00387912), who retires by rotation and being eligible offers himself for Re-appointment 3. To Appoint M/s. Ladha Singhal & Associates, Chartered Ordinary Resolution Accountants (Firm Registration No. 120241W) as the Statutory Auditors of the Company for a first term of 5 years. SPECIAL BUSINESS: 4. To approve the Material Related Party Transactions Ordinary Resolution L with Naxpar Pharma Private Limited The Company Secretary thereafter informed the Shareholders about the e-voting facility and e- voting process and invited the Shareholders to put forth their views/questions, if any relating to the annual financial statements, for the year ended March 31, 2026, and matters related thereto. No Registered speakers have attended the meeting through Video Conferencing means. Allresolutions placed in the meeting were carried out with the requisite majority. The Company Secretary then informed that pursuant to the provisions of Section 108 of the Companies Act, 2013 read with rule 20 of the Companies (Management and Administration) Rules, 2014, as amended and Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company had extended remote E-Voting facility in respect of all businesses to be transacted at the 44% Annual General Meeting to all the members holding shares as on cut-off date of Tuesday, September 22, 2026, and E-voting period commenced on Saturday, September 26, 2026, at 9:00 A.M. and ended on Monday, September 28, 2026, at 5:00 P.M. Mr. Kunal Sakpal, Practicing Company Secretary, Designated Partner of M/s. HSPN & Associates LLP was appointed as a Scrutinizer by the Board to scrutinize the voting process in a fair and transparent manner. Works : Plot No. 120, Masat Ind. Estate, Dadra & Nagar Haveli, Silvassa-396230 (India) ) Plot No. 121 & 74, Masat. Ind. Estate, Dadra & Nagar Haveli, Silvassa-396230 (India) T =mmes Darnax Lab Ltd. ISit us at : www. CIN No. : L36912MH1882PLC027925 114, BLDG, NO. 8, JOGANI IND. COMPLEX, SION-CHUNABHATTI, MUMBAI - 400 022, INDIA The outc [Showing first 8,000 characters — download PDF for full document]